Skip to main content
. 2020 Feb 28;35(2):276–283. doi: 10.3904/kjim.2020.035

Figure 2.

Figure 2.

Mechanism of action of phosphodiesterase-4 inhibitors (PDE4Is) in chronic obstructive pulmonary disease (COPD). cAMP, cyclic adenosine monophosphate; CFTR, cystic fibrosis transmembrane conductance regulator; ASL, airway-surface liquid; MUC5AC, mucin 5AC; HDAC2, histone deacetylase 2; GR, glucocorticoid receptor; ROS, reactive oxygen species; TLR3, toll-like receptor 3.